Literature DB >> 6653618

Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat--III: Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid.

G Campistron, R Guiraud, J Cros, H Pontagnier.   

Abstract

Changes in the levels of amino acids in the plasma, liver and brain were studied in rats after simultaneous administration of 0.1 mmol/rat of arginine and aspartic acid. The levels of most of the assayed amino acids underwent various changes some of which only occurred in one of the organs studied, for example, GABA in the brain and proline in the liver. It is difficult to advance any explanation. Meanwhile some of changes can be explained on the grounds of well-known metabolic changes. The large increase of ornithine in the liver may be due to the action of arginase in the first stage in the urea cycle. This amino acid is the precursor of glutamic acid and proline which may explain the high levels of these two amino acids observed especially in the liver. The increase of GABA in the brain may be due to the simultaneous administration of arginine and aspartic acid which could induce the formation of ornithine and alpha-ketoglutaric acid respectively, two metabolites known to increase cerebral GABA. The increases in Ser, Gly, and Ala observed in practically all the tissues studied may be due to the formation of oxaloacetate from aspartic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653618     DOI: 10.1007/BF03188758

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  [Action of arginine in a recurrent hepatic coma complicating a feminizing tumor of the adrenal cortex with hepatic metastases].

Authors:  M Imler; H Ruscher; B Peter; D Kurtz; J Stahl
Journal:  Sem Hop       Date:  1973-11-26

2.  [Effects of arginine aspartate administration on somatotrophin, insulin and glucagon secretion in rat (author's transl)].

Authors:  P Franchimont; A Luyckx; G Campistron; J Cros
Journal:  Therapie       Date:  1979 Sep-Oct       Impact factor: 2.070

3.  The measurement of circulating blood volume and of the blood volume impregnating organs in rat and rabbit, using 113mIn-labelled transferrin.

Authors:  G Campistron; J Fabre; R Guiraud; R Le Net; J Cros; A Puget
Journal:  Int J Nucl Med Biol       Date:  1979

4.  Leucin-enkephalin plasma levels after an oral or intravenous arginine stimulation in rats.

Authors:  G Sachse; H Laube
Journal:  Horm Metab Res       Date:  1980-08       Impact factor: 2.936

5.  Effect of arginine on serum-levels of human growth-hormone.

Authors:  T J Merimee; D A Lillicrap; D Rabinowitz
Journal:  Lancet       Date:  1965-10-02       Impact factor: 79.321

6.  Effects of arginine infusion in infants: increased urea synthesis associated with unchanged ammonia blood levels.

Authors:  H Kraus; P Stubbe; W von Berg
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

Review 7.  Absorption, utilization, and safety of aspartic acid.

Authors:  L D Stegink
Journal:  J Toxicol Environ Health       Date:  1976-09

8.  Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: II. Tissue distribution.

Authors:  G Campistron; R Guiraud; J Cros; G Prat
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

9.  Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro.

Authors:  A V Schally; T W Redding; A Arimura; A Dupont; G L Linthicum
Journal:  Endocrinology       Date:  1977-03       Impact factor: 4.736

10.  Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone.

Authors:  F Cavagnini; G Benetti; C Invitti; G Ramella; M Pinto; M Lazza; A Dubini; A Marelli; E E Müller
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.